Login / Signup

Developments over the last 60 years in diffuse large B-cell lymphomas.

David C Linch
Published in: British journal of haematology (2021)
At the time of the formation of the British Society of Haematology diffuse large B-cell lymphoma was not recognised as a specific entity and was included in the category of 'large cell' or 'aggressive' lymphomas. These were fatal in 95% of cases. Today the cure rate in adults entered into clinical trials is ~70% and a large number of British physicians have contributed to this progress.
Keyphrases
  • diffuse large b cell lymphoma
  • clinical trial
  • epstein barr virus
  • primary care
  • single cell
  • cell therapy
  • low grade
  • stem cells
  • phase ii
  • bone marrow
  • open label